| Abbreviation | Definition |
| A549 | Human alveolar epithelial cell line |
| ABPA | Allergic bronchopulmonary aspergillosis |
| ABPA-CB | ABPA with central bronchiectasis |
| ABPM | Allergic bronchopulmonary mycosis |
| AFAD | Allergic fungal airway disease |
| AHR | Airway hyperresponsiveness |
| APC | Antigen-presenting cell |
| ASM | Airway smooth muscle |
| ATLANTIS | Assessment of Small Airways Involvement in Asthma |
| BAL | Bronchoalveolar lavage |
| BALB/c | Inbred laboratory mouse strain |
| BEAS-2B | Human bronchial epithelial cell line |
| BUPAS | Belarus, Ukraine, Poland Asthma Study |
| CARD9 | Caspase recruitment domain–containing protein 9 |
| CASCADE | Mechanistic biopsy substudy of tezepelumab in asthma |
| CF | Cystic fibrosis |
| CHIT1 | Chitotriosidase 1 gene |
| CI | Confidence interval |
| CLCA1 | Calcium-activated chloride channel regulator 1 |
| CLEC7A | C-type lectin domain containing 7A (encodes Dectin-1) |
| CLR | C-type lectin receptor |
| co-stim | Co-stimulatory signal |
| CO2 | Carbon dioxide |
| COPD | Chronic obstructive pulmonary disease |
| CRD | Component-resolved diagnostics |
| DALY | Disability-adjusted life year |
| DC/DCs | Dendritic cell/dendritic cells |
| Dectin-1/Dectin-2 | Dendritic cell–associated C-type lectin receptors 1 and 2 |
| DESTINATION | Long-term extension study of tezepelumab |
| DH | Dehydrogenase |
| diHOME | Dihydroxyoctadecenoic acid |
| EAACI | European Academy of Allergy and Clinical Immunology |
| ECAP | Epidemiology of Allergic Diseases in Poland |
| ECM | Extracellular matrix |
| ECP | Eosinophil cationic protein |
| ECRHS | European Community Respiratory Health Survey |
| EDN | Eosinophil-derived neurotoxin |
| ELISA | Enzyme-linked immunosorbent assay |
| EMA | European Medicines Agency |
| EMT | Epithelial–mesenchymal transition |
| EPO | Eosinophil peroxidase |
| EVITA3 | Voriconazole in Aspergillus fumigatus–associated asthma trial |
| FAST | Fungal Asthma Sensitization Trial (itraconazole) |
| FcεRI | High-affinity immunoglobulin E receptor |
| FDA | U.S. Food and Drug Administration |
| FeNO | Fractional exhaled nitric oxide |
| FEV1 | Forced expiratory volume in 1 s |
| FLG | Filaggrin gene |
| FUT2 | α(1,2)-fucosyltransferase 2 gene/secretor status |
| FVC | Forced vital capacity |
| GAN | Global Asthma Network |
| GATA3 | GATA-binding protein 3 |
| GBD | Global Burden of Disease |
| GBMI | Global Biobank Meta-analysis Initiative |
| GC | Germinal center |
| GINA | Global Initiative for Asthma |
| GM-CSF | Granulocyte–macrophage colony-stimulating factor |
| GWAS | Genome-wide association study |
| Hev b 9 | Hevea brasiliensis enolase (latex allergen) |
| HLA-DRB1 | Human leukocyte antigen DR beta 1 |
| Hsp 90 | Heat shock protein 90 |
| HVAC | Heating, ventilation, and air conditioning |
| ICS | Inhaled corticosteroids |
| ICS/LABA | Inhaled corticosteroid/long-acting β2-agonist combination |
| IFN-γ | Interferon-gamma |
| IgA | Immunoglobulin A |
| IgE | Immunoglobulin E |
| IgG | Immunoglobulin G |
| IL | Interleukin |
| IL-1β | Interleukin 1 beta |
| IL-4 | Interleukin 4 |
| IL-4Rα | Interleukin-4 receptor alpha chain |
| IL-5 | Interleukin 5 |
| IL-5R | Interleukin-5 receptor |
| IL-6 | Interleukin 6 |
| IL-8 | Interleukin 8 |
| IL-9 | Interleukin 9 |
| IL-13 | Interleukin 13 |
| IL-17A | Interleukin 17A |
| IL-17F | Interleukin 17F |
| IL-22 | Interleukin 22 |
| IL-23 | Interleukin 23 |
| IL-25 | Interleukin 25 |
| IL-25R | Interleukin-25 receptor |
| IL-33 | Interleukin 33 |
| IL-36 | Interleukin 36 |
| ILC2 | Group 2 innate lymphoid cell |
| ISAAC | International Study of Asthma and Allergies in Childhood |
| ISHAM | International Society for Human and Animal Mycology |
| ISU | ISAC standardized units |
| IUIS | International Union of Immunological Societies |
| LABA | Long-acting β2-agonist |
| LAMA | Long-acting muscarinic antagonist |
| LC-MS/MS | Liquid chromatography–tandem mass spectrometry |
| MAPCAH | Melbourne Air Pollen Children and Adolescent Health |
| MART | Maintenance and reliever therapy |
| MBP | Major basic protein |
| MHC-II | Major histocompatibility complex class II |
| Mincle | Macrophage-inducible C-type lectin |
| Mn-SOD | Manganese superoxide dismutase |
| MUC5AC | Mucin 5AC |
| MΦ | Macrophage |
| NAVIGATOR | Phase 3 trial of tezepelumab in severe, uncontrolled asthma |
| NCN | Polish National Science Centre (Narodowe Centrum Nauki) |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NHBE | Normal human bronchial epithelial cells |
| NLR | NOD-like receptor |
| OCS | Oral corticosteroids |
| ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 |
| OVA | Ovalbumin |
| P2 | Ribosomal P2 protein |
| PAMP | Pathogen-associated molecular pattern |
| PAR-2 | Protease-activated receptor 2 |
| PGE2 | Prostaglandin E2 |
| PMSEAD | The Polish Multicentre Study of Epidemiology of Allergic Diseases |
| PPIs | Proton-pump inhibitors |
| PRR | Pattern-recognition receptor |
| PRS | Polygenic risk score |
| RNase | Ribonuclease |
| RORγt | Retinoic acid receptor-related orphan receptor gamma t |
| ROS | Reactive oxygen species |
| SABA | Short-acting β2-agonist |
| SAFS | Severe asthma with fungal sensitization |
| SAMA | Short-acting muscarinic antagonist |
| SDI | Socio-demographic index |
| SFTPA2 | Surfactant protein A 2 |
| sIgE | Allergen-specific IgE |
| SMC | Smooth muscle cell |
| SNP | Single-nucleotide polymorphism |
| SP-A/SP-D | Surfactant protein A/D |
| SPT | Skin prick test |
| ST2 | Suppression of tumorigenicity 2 (IL-33 receptor) |
| STAT | Signal transducer and activator of transcription |
| Syk | Spleen tyrosine kinase |
| TAGC | Trans-National Asthma Genetic Consortium |
| TEER | Transepithelial electrical resistance |
| Tfh | T follicular helper cell |
| Tfh13 | IL-13-producing T follicular helper cell |
| TGF-β | Transforming growth factor beta |
| Th1 | T-helper cell type 1 |
| Th2 | T-helper cell type 2 |
| Th17 | T-helper cell type 17 |
| TLR | Toll-like receptor |
| TLR2 | Toll-like receptor 2 |
| TLR4 | Toll-like receptor 4 |
| TNF | Tumor necrosis factor |
| TNF-α | Tumor necrosis factor alpha |
| Treg | Regulatory T cell |
| Trx | Thioredoxin |
| TSLP | Thymic stromal lymphopoietin |
| TSLPR | Thymic stromal lymphopoietin receptor |
| U-BIOPRED | Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes |
| VEGF | Vascular endothelial growth factor |
| WGA-FITC | Wheat germ agglutinin conjugated to fluorescein isothiocyanate |
| WHO | World Health Organization |